المؤلفون: A. M. Talyzin, S. V. Zhuravel, M. Sh. Khubutiya, E. A. Tarabrin, N. K. Kuznetsova, А. М. Талызин, С. В. Журавель, М. Ш. Хубутия, Е. А. Тарабрин, Н. К. Кузнецова

المصدر: Transplantologiya. The Russian Journal of Transplantation; Том 14, № 2 (2022); 132-141 ; Трансплантология; Том 14, № 2 (2022); 132-141 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2022-14-2

مصطلحات موضوعية: ишемически-реперфузионное повреждение, inhaled nitric oxide, intraoperative period, early postoperative period, primary graft dysfunction, ischemia-reperfusion injury, оксид азота, ингаляционный оксид азота, интраоперационный период, ранний послеоперационный период, первичная дисфункция трансплантата

وصف الملف: application/pdf

العلاقة: https://www.jtransplantologiya.ru/jour/article/view/652/681Test; Jin Z, Suen KC, Wang Z, Ma D. Review 2: Primary graft dysfunction after lung transplant–pathophysiology, clinical considerations and therapeutic targets. J Anesth. 2020;34(5):729–740. PMID: 32691226 https://doi.org/10.1007/s00540-020-02823-6Test; Meade MO, Granton JT, Matte-Martyn A, McRae K, Weaver B, Cripps P, et al. A randomized trial of inhaled nitric oxide to prevent ischemia–reperfusion injury after lung transplantation. Am J Respir Crit Care Med. 2003;167(11):14831489. PMID: 12770854 https://doi.org/10.1164/rccm.2203034Test; Yoon J, Salamanca-Padilla Y. Effect of left ventricular diastolic dysfunction on development of primary graft dysfunction after lung transplant. Curr Opin Anaesthesiol. 2020;33(1):10–16. PMID: 31789901 https://doi.org/10.1097/ACO.0000000000000811Test; Fiser SM, Tribble CG, Long SM, Kaza AK, Kern JA, Jones DR, et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg. 2002;73(4):1041-1047. PMID: 11996238 https://doi.org/10.1016/s0003-4975Test(01)03606-2; Голиков П.П. Оксид азота в клинике неотложных заболеваний. Москва: Медпрактика-М; 2004.; Хубутия М.Ш., Клычникова Е.В., Тазина Е.В., Тарабрин Е.А., Первакова Э.И., Романов А.А. и др. Динамика концентрации нитрита/нитрата и метгемоглобина в крови больных послетрансплантации легких на фоне применения ингаляционного оксида азота. Трансплантология. 2014;4:6–11.; Naka Y, Chowdhury NC, Liao H, Roy DK, Oz MC, Michler RE, et al. Enhanced preservation of orthotopically transplanted rat lungs by nitro glycerin but not hydralazine: requirement for graft vascular homeostasis beyond harvest vasodilation. Circ Res. 1995;76(5):900–906. PMID: 7729008 https://doi.org/10.1161/01.res.76.5.900Test; Karamsetty MR, Klinger JR. NO: more than just a vasodilator in lung trans plantation. Am J Respir Cell Mol Biol. 2002;26(1):1–5. PMID: 11751196 https://doi.org/10.1165/ajrcmb.26.1.f223Test; Minamoto K, Pinsky DJ, Fujita T, Naka Y. Timing of nitric oxide donor supplementation determines endothelin-1 regulation and quality of lung preser vation for transplantation. Am J Respir Cell Mol Biol. 2002;26(1):14–21. PMID: 11751199 https://doi.org/10.1165/ajrcmb.26.1.4649Test; Lindemann S, Sharafi M, Spiecker M, Buerke M, Fisch A, Grosser T, et al. NO reduces PMN adhesion to human vascular endothelial cells due to downregulation of ICAM-1 mRNA and surface expression. Thromb Res. 2000;97(3):113–123. PMID: 10680642 https://doi.org/10.1016/s0049-3848Test(99)00162-0; Pinsky DJ, Naka Y, Chowdhury NC, Liao H, Oz MC, Michler RE, et al. The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. Proc Natl Acad Sci USA. 1994;91(25):12086–12090. PMID: 7527550 https://doi.org/10.1073/pnas.91.25.12086Test; Liu M, Tremblay L, Cassivi SD, Bai XH, Mourgeon E, Pierre AF, et al. Alterations of nitric oxide synthase expression and activity during rat lung transplantation. Am J Physiol Lung Cell Mol Physiol. 2000;278(5):L1071-L1081. PMID: 10781440 https://doi.org/10.1152/ajplung.2000.278.5.L1071Test; Schutte H, Witzenrath M, Mayer K, Rosseau S, Seeger W, Grimminger F. Short-term “preconditioning” with inhaled nitric oxide protects rabbit lungs against ischemia-reperfusion injury. Transplantation. 2001;72(8):1363-1370. PMID: 11685104 https://doi.org/10.1097/00007890-200110270-00005Test; Tagawa T, Suda T, Daddi N, Kozower BD, Kanaan SA, Mohanakumar T, et al. Low-dose endobronchial gene transfer to ameliorate lung graft ischemia-reperfusion injury. J Thorac Cardiovasc Surg. 2002;123(4):795–802. PMID: 11986609 https://doi.org/10.1067/mtc.2002.119067Test; Thabut G, Brugiere O, Leseche G, Stern JB, Fradj K, Herve P, et al. Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplanta tion. Transplantation. 2001;71(9):1295-1300. PMID: 11397965 https://doi.org/10.1097/00007890-200105150-00019Test; Kawashima M, Bando T, Nakamura T, Isowa N, Liu M, Toyokuni S, et al. Cytoprotective effects of nitroglycerin in ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med. 2000;161(3 Pt 1):935–943. PMID: 10712346 https://doi.org/10.1164/ajrccm.161.3.9905003Test; Ardehali A, Laks H, Levine M, Shpiner R, Ross D, Watson LD, et al. A prospective trial of inhaled nitric oxide in clinical lung transplanta tion. Transplantation. 2001;72(1):112-115. PMID: 11468544 https://doi.org/10.1097/00007890-200107150-00022Test; Adatia I, Lillehei C, Arnold JH, Thompson JE, Palazzo R, Fackler JC, et al. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. Ann Tho rac Surg. 1994;57(5):1311–1318. PMID: 8179406 https://doi.org/10.1016/00034975Test(94)91382-x; Date H, Anastosios NT, Trulock EP, Pohl MS, Cooper JD, Patterson GA. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg. 1996;111(5): 913–919. PMID: 8622313 https://doi.org/10.1016/s0022-5223Test(96)70364-1; Yerebakan C, Ugurlucan M, Bayraktar S, Bethea BT, Conte JV. Effects of inhaled nitric oxide following lung transplantation. J Card Surg. 2009;24(3):269–274. PMID: 19438780 https://doi.org/10.1111/j.1540-8191.2009.00833.xTest; Fessler J, Godement M, Pirracchio R, Marandon J-Y, Thes J, Sage E, et al. Inhaled nitric oxide dependency at the end of double-lung transplantation: a boosted propensity score cohort analysis. Transpl Int. 2019;32(3):244–256. PMID: 30449027 https://doi.org/10.1111/tri.13381Test; Курилова О.А., Журавель С.В., Романова А.А., Маринин П.Н., Цурова Д.Х., Каллагов Т.Э. и др. Опыт применения экстракорпоральной мембранной оксигенации для обеспечения двусторонней трансплантации легких. Вестник трансплантологии и искусственных органов. 2014;(2):66–74. https://doi.org/10.15825/1995-1191-2014-2-66-74Test; Хубутия М.Ш., Чучалин А.Г., Тарабрин Е.А., Первакова Э.И., Гасанов А.М., Боровкова Н.В. и др. (сост.) Алгоритм лечения первичной дисфункции легочного трансплантата и защита донорских легких: методические рекомендации № 39. Москва: НИИ СП им. Н.В. Склифосовского; 2017.; https://www.jtransplantologiya.ru/jour/article/view/652Test

الإتاحة: https://doi.org/10.23873/2074-0506-2022-14-2-132-141Test
https://doi.org/10.23873/2074-0506-2022-14-2Test
https://doi.org/10.1007/s00540-020-02823-6Test
https://doi.org/10.1164/rccm.2203034Test
https://doi.org/10.1097/ACO.0000000000000811Test
https://doi.org/10.1016/s0003-4975Test(01)03606-2
https://doi.org/10.1161/01.res.76.5.900Test
https://doi.org/10.1165/ajrcmb.26.1.f223Test
https://doi.org/10.1165/ajrcmb.26.1.4649Test
https://doi.org/10.1016/s0049-3848Test(99)00162-0

المؤلفون: O. Chugunova A., A. Dzyadz'ko M., A. Shcherba E., M. Katin L., D. Efimov Yu., A. Minov F., О. Чугунова А., А. Дзядзько М., А. Щерба Е., М. Катин Л., Д. Ефимов Ю., А. Минов Ф.

المصدر: Transplantologiya. The Russian Journal of Transplantation; Том 9, № 4 (2017); 299-305 ; Трансплантология; Том 9, № 4 (2017); 299-305 ; 2542-0909 ; 2074-0506 ; 10.23873/2074-0506-2017-9-4

مصطلحات موضوعية: interleukin-6, c-reactive protein, procalcitonin, liver transplantation, infectious complications, postoperative period, интерлейкин-6, С-реактивный белок, прокальцитонин, трансплантация печени, инфекционные осложнения, послеоперационный период

وصف الملف: application/pdf

العلاقة: https://www.jtransplantologiya.ru/jour/article/view/196/244Test; Maddrey W.C., Schiff E.R., Sorrell M.F. Transplantation of the liver. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2001.; Журавель С.В., Кузнецова Н.К., Черненькая Т.В., Уткина И.И. Передача инфекционных возбудителей от донора органов реципиенту. Нужны ли изменения в оценке рисков? Трансплантология. 2015;(1):7–12.; Jalan R., Fernandez J., Wiest R., et al. Bacterial infections in cirrhosis: A position statement based on the Conference 2013. J. Hepatol. 2014;60(6):1310–1324. PMID:24530646 DOI:10.1016/j.jhep.2014.01.024; Eyraud D., Ayed S., Tanguy M. L., et al. Procalcitonin in liver transplantation: are high levels due to donors or recipients? Critical Care. 2008;12:R85. DOI:10.1186/cc6942; Dembic Z. The Cytokines of the Immune System:The Role of Cytokines in Disease Related to Immune Response. Сhapter 6: Cytokines of the Immune System: Interleukins. – Elsevier, Academic press. 2015: 143-239.; Jani A., Chen P. Infections After Solid Organ Transplantation. Electronic resource. Medscape. URL: https://emedicine.medscape.com/article/430550-overviewTest; Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644–1655. PMID:1303622 DOI:10.1378/chest.101.6.1644; Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 2003;31(4):1250–1256. PMID:12682500 DOI:10.1097/01.CCM.0000050454.01978.3B; Rhodes A., Evans L.E., Alhazzani W., et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304–377. PMID:28101605 DOI:10.1007/s00134-017-4683-6; Mokart D., Merlin M., Sannini A., et al. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaest. 2005;94(6):767–773. PMID:15849208 DOI:10.1093/bja/aei143; Qu J., L X., Liu Y., Wang X. Evaluation of procalcitonin, c-reactive protein, interleukin 6 and serum amyloid as diagnostic biomarkers of bacterial infection in febrile patients. Indian J. Med. Res. 2015;141(3):315–321. PMID:25963492; Lin S, Zhu Y, Huang Z, et al. Interleukin-6 as an early diagnostic marker for bacterial sepsis in patient with liver cirrhosis. J. Critical Care. 2015;30(4):732–738. PMID:25891645 DOI:10.1016/j.jcrc.2015.03.031; Zant R., Melter M., Knoppke B., et al. Kinetics of Interleukin-6, procalcitonin and c-reactive protein after pediatric liver transplantation. Transplant. Proc. 2014;46(10):3507-3510. PMID:25498081 DOI:10.1016/j.transproceed.2014.08.048; Дзядзько А.М., Щерба А.Е., Руммо О.О., и др. Парадокс: печеночная недостаточность «защищает» больного? Трансплантология. 2017;(1):52–70. DOI:10.23873/2074-0506-2017-9-1-52-70; Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140(6):805–820. PMID:20303872 DOI:10.1016/j.cell.2010.01.022; Olthoff K.M., Kulik L., Samstain B., et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver transplant. 2010;16(8):943–949. PMID:20677285 DOI:10.1002/lt.22091; https://www.jtransplantologiya.ru/jour/article/view/196Test

الإتاحة: https://doi.org/10.23873/2074-0506-2017-9-4-299-305Test
https://doi.org/10.23873/2074-0506-2017-9-4Test
https://doi.org/10.1016/j.jhep.2014.01.024Test
https://doi.org/10.1378/chest.101.6.1644Test
https://doi.org/10.1097/01.CCM.0000050454.01978.3BTest
https://doi.org/10.1007/s00134-017-4683-6Test
https://doi.org/10.1093/bja/aei143Test
https://doi.org/10.1016/j.jcrc.2015.03.031Test
https://doi.org/10.1016/j.transproceed.2014.08.048Test
https://doi.org/10.1016/j.cell.2010.01.022Test